| Rank |
Status |
Study |
| 1 |
Recruiting
|
Safety and Efficacy of Propranolol Eye Drops in Treating Retinopathy of Premature
| Condition: |
Retinopathy of Prematurity |
| Intervention: |
Drug: Propranolol eye drops |
| Outcome Measures: |
Incidence rate of progression from stage 2 ROP to more severe stage ROP (stage 2 or 3 with plus, stage 4 and stage 5); Plasma concentrations of Propranolol at the steady state; Number of newborns who progress to Stage 3 without plus ROP; Number of newborns who progress to Stage 4 or 5 ROP with total or partial retinal detachment; Number of newborns who need laser treatment; Number of newborns who need rescue treatment with bevacizumab; Number of newborns who need vitrectomy; Collection of adverse events due to eye drop Propranolol treatment |
|
| 2 |
Not yet recruiting
|
Efficacy of Propranolol Treatment to Prevent Melanoma Progression
| Conditions: |
Stages III Skin Melanoma; Stages II Skin Melanoma; Stage IB Skin Melanoma |
| Interventions: |
Drug: Propranolol hydrochloride; Drug: Placebo pill |
| Outcome Measures: |
Efficacy of Propranolol on progression free survival for patients suffering from a primary melanoma with a high risk of recurrence; Use of serum microRNA profile as a predictor for recurrence; Overall survival |
|
| 3 |
Recruiting
|
Propanolol and Red Cell Adhesion Non-asthmatic Children Sickle Cell Disease
| Condition: |
Sickle Cell Disease |
| Intervention: |
Drug: Propranolol |
| Outcome Measures: |
measurement of the sickle red cell response to epinephrine; Safety data regarding the use of propanolol in children with sickle cell disease |
|
| 4 |
Recruiting
|
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
| Condition: |
Locally Advanced Breast Cancer |
| Interventions: |
Drug: Propranolol; Other: Breast imaging - Diffuse Optical Tomography (DOT) |
| Outcome Measures: |
Percentage of patients who are compliant with taking > 80% take the drug while on chemotherapy.; Changes in angiogenesis; Changes in stress levels; Number of Patients with Adverse Events; Change in DOT-derived parameters; Changes in tumor proliferation |
|
| 5 |
Unknown †
|
Propranolol Treatment of Traumatic Memories (PTTM)
| Conditions: |
Traumatic Memory; Posttraumatic Stress Disorder |
| Interventions: |
Drug: Propranolol Hydrochloride; Drug: Placebo |
| Outcome Measures: |
The primary endpoint will be changes between the pretreatment and posttreatment scores in the Clinician Assessment Posttraumatic Scale (CAPS), Impact of Event Scale (IES) and Traumatic Memory Description Measure (TMDM) instruments.; The secondary endpoint will be changes between the treatment and posttreatment score in the other scales used - MINI, ZAS, ZDS and NIHS. |
|
| 6 |
Recruiting
|
Perioperative Propranolol in Patients With Post Traumatic Stress Disorder (PTSD)
| Condition: |
Post-traumatic Stress Disorder |
| Interventions: |
Drug: Propranolol Hydrochloride; Other: Placebo |
| Outcome Measures: |
ICU length of stay; Hospital length of stay; Postoperative delirium; Postoperative renal dysfunction; Perioperative complications; Pain intensity; Pain unpleasantness; Analgesics use; Length of intubation and mechanical ventilation; Post Traumatic Stress Disorder symptomatology; Quality of Life; Functional status; Sleep Quality; Depression symptoms; Postoperative Neurocognitive Dysfunction Score; 30-day, 3-month, and 1-year mortality; Postoperative complications |
|
| 7 |
Recruiting
|
Efficacy of Clonidine and Propranolol in Dentistry (AAA)
| Condition: |
Anxiety |
| Interventions: |
Drug: Clonidine; Drug: Propranolol; Drug: Placebo |
| Outcome Measures: |
Change from baseline in modified dental anxiety scale(MDAS)and vital signs (blood pressure, heart rate, respiratory rate, oxygen saturation) until four hours post treatment; Changes in Verbal Numerical Rating Scale (VNRS) at three, six, and twenty-four hours post treatment |
|
| 8 |
Unknown †
|
Reducing Reconsolidation of Trauma Memories With Propranolol
| Condition: |
Posttraumatic Stress Disorder |
| Interventions: |
Drug: Propranolol; Drug: Short acting + long acting Propranolol + memory reactivation |
| Outcome Measures: |
Electromyogram; Heart rate; Skin conductance; PTSD symptom levels; Quality of life; Memory Experience; Psychophysiological assessments |
|
| 9 |
Unknown †
|
Endoscopic Band Ligation (EBL) Versus Propranolol for Primary Prophylaxis of Variceal Bleeding
| Conditions: |
Variceal Bleeding; Cirrhosis |
| Interventions: |
Procedure: Endoscopic band ligation; Drug: Propranolol; Procedure: endoscopic band ligation and Propranolol |
| Outcome Measures: |
First esophageal variceal bleeding; Mortality; Significant esophageal variceal bleeding; Upper gastrointestinal bleeding except esophageal bleeding; Adverse events |
|
| 10 |
Unknown †
|
A Psychophysiologic Study of Weakening Traumatic Combat Memories With Post-Reactivation Propranolol
| Condition: |
Post-Traumatic Stress Disorder |
| Intervention: |
Drug: Propranolol |
| Outcome Measure: |
Psychophysiologic responses during script-driven imagery of combat events |
|
| 11 |
Unknown †
|
A Novel Treatment For Chronic Posttraumatic Stress Disorder (PTSD) Using Post-Reactivation Propranolol
| Condition: |
Stress Disorders, Post-Traumatic |
| Intervention: |
Drug: Propranolol is available in generic form as the Wyeth product under the trade name Inderal. |
| Outcome Measures: |
Clinician-Administered PTSD Scale (CAPS) for DSM-IV; Mini International Neuropsychiatric Interview (MINI); Peritraumatic Distress Inventory (PDI); The Peritraumatic Dissociative Experiences Questionnaire; PTSD Check List (PCL) civilian version; Script-driven imagery psychophysiological measurement |
|
| 12 |
Recruiting
|
Propranolol in Severely Burned Children
| Condition: |
Burn |
| Interventions: |
Drug: Propranolol; Drug: Placebo |
| Outcome Measures: |
Resting heart rate multiplied by the systolic blood pressure measurement= rate pressure product; Number of deaths |
|
| 13 |
Recruiting
|
Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas
| Condition: |
Hemangioma of Infancy |
| Interventions: |
Drug: Propranolol; Drug: Prednisolone |
| Outcome Measures: |
reduction in size of hemangioma; Tolerability of medication |
|
| 14 |
Recruiting
|
The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma
| Condition: |
Hemangioma |
| Interventions: |
Drug: Prednisolone; Drug: Propranolol |
| Outcome Measures: |
Hemangioma volume measured by MRI or SONO; Size changes from baseline; Heart rate change from Baseline at 16 weeks; Change from Baseline in color; Changes in Size of Ulceration; Whether or not Re-epithelized in 16weeks; Stop time of proliferation; Time of regression; Drug compliance within 16 weeks; Change from Baseline in systolic blood pressure at 16 weeks; Changes from baseline in Glucose level at 16 weeks; Whether the facial edema occurs within 16 weeks; Whether growth retardation occurs within 16 weeks; Whether the Gastroesophageal reflux occurs within 16 weeks; Number of Participants with Adverse drug reaction |
|
| 15 |
Recruiting
|
Protective Effects of Propranolol in Adults
| Condition: |
Burn |
| Interventions: |
Drug: Propranolol; Drug: Placebo |
| Outcome Measures: |
Cardiac rate pressure product; Mortality rates |
|
| 16 |
Recruiting
|
Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients
| Conditions: |
Liver Cirrhosis; Portal Hypertension |
| Interventions: |
Drug: Rifaximin + Propranolol; Drug: Propranolol + Placebo |
| Outcome Measures: |
Hepatic vein pressure gradient(HVPG); occurence of gastrointestinal bleeding |
|
| 17 |
Recruiting
|
Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma
| Condition: |
Hemangioma |
| Interventions: |
Drug: Acebutolol; Drug: Propanolol |
| Outcome Measures: |
Hemangioma size; Tolerance of treatment; Proportion of patients requiring treatment with corticosteroids because of the evolution of a 'serious' hemangioma |
|
| 18 |
Recruiting
|
Early Propranolol After Traumatic Brain Injury: Phase II
| Condition: |
Traumatic Brain Injury |
| Intervention: |
Drug: Propranolol |
| Outcome Measure: |
Determine in patients with traumatic brain injury (TBI) the safe dosing of early Propranolol. |
|
| 19 |
Unknown †
|
Propranolol for Diabetic Retinopathy
| Condition: |
Proliferative Diabetic Retinopathy |
| Intervention: |
Drug: Propranolol |
| Outcome Measures: |
Area of retinal neovascularization on fundus photography; Retinopathy level in contralateral eye; Optical coherence tomography macular thickness of treated and fellow eye; Amount of fluorescein leakage on angiography; Early Treatment Diabetic Retinopathy Study visual acuity in study and fellow eye |
|
| 20 |
Recruiting
|
Treatment of PTSD by Reduction of Traumatic Memory Reconsolidation by Propranolol : a Multisite Trial
| Condition: |
Post-traumatic Stress Disorder |
| Interventions: |
Drug: Propranolol; Other: Trauma reactivation; Drug: placebo |
| Outcome Measure: |
PTCD CheckList (PCL) total score. |
|
